Neuro Spectrum Insights, Inc. is a medical device company focused on commercializing advanced computerized analysis technology for diagnosing neurological and neurodevelopmental disorders. Their first product, GyriCalc, is a patented software solution aimed at aiding the early diagnosis of autism through automated MRI image analysis. The company aims to introduce GyriCalc initially in the U.S. and Canada, with FDA approval anticipated in 2025. Currently, the company does not generate any revenue, concentrating on product launch and market entry.
NSI intends to generate revenue through the marketing of GyriCalc to clinicians who will order MRI scans analyzed by the software. The scans are primarily paid for by patients, often covered by medical insurance, with the projected list price for GyriCalc set at $1,500 per patient.
Not disclosed in the provided filing text.
This summary is generated automatically from the company's own filing and may contain errors or omissions. It is a reading aid, not a substitute for the filing itself, and it is not advice.
Underwriters on the deal include Network 1. Neuro Spectrum Insights, Inc. is headquartered in United States and incorporated in DE. It is classified under Surgical & Medical Instruments & Apparatus.
Neuro Spectrum Insights, Inc. has filed 3 times, starting with a S1/A on Jul 10, 2026.
Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with Neuro Spectrum Insights, Inc..
Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.
<iframe src="https://www.discoveripo.com/embed/neuro-spectrum-insights" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="Neuro Spectrum Insights, Inc. — DiscoverIPO"></iframe>
Dark by default. For a light background, use https://www.discoveripo.com/embed/neuro-spectrum-insights?theme=light as the src instead.
https://www.discoveripo.com/ipo/neuro-spectrum-insights/opengraph-image
Neuro Spectrum Insights, Inc. IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/neuro-spectrum-insights?utm_source=embed&utm_medium=text&utm_campaign=neuro-spectrum-insights
Get emailed when Neuro Spectrum Insights, Inc.'s terms, price, or expected date change — no weekly noise, just this company.
Registration statement filed with the U.S. Securities and Exchange Commission. Retrieved Oct 5, 2026.
View the original filing on SEC EDGAR →How this offering's SEC filings changed over time. Only SEC-sourced filings carry a full amendment history to compare; other regulators publish a single filing with no prior version to diff against.
Initial filing.
No tracked deal terms changed in this amendment.
No tracked deal terms changed in this amendment.
Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public securities-regulator filings, may be incomplete or out of date, and should be verified against the original source before you act on them.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy